Enhanced expression of cyclooxygenase-2 and prostaglandin E 2 in response to endotoxin after trauma is dependent on MAPK and NF-κB mechanisms

Macrophage prostaglandin E 2 (PGE 2) production is important in cellular immune suppression and in affecting the potential development of sepsis after trauma. We hypothesized that macrophage PGE 2 production after trauma is regulated by mitogen-activated protein kinase (MAPK) and nuclear factor kapp...

Full description

Saved in:
Bibliographic Details
Published in:Cellular immunology Vol. 232; no. 1; pp. 116 - 126
Main Authors: Yan, Zhaoping, Stapleton, Philip P., Freeman, Tracy A., Fuortes, Michele, Daly, John M.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-11-2004
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Macrophage prostaglandin E 2 (PGE 2) production is important in cellular immune suppression and in affecting the potential development of sepsis after trauma. We hypothesized that macrophage PGE 2 production after trauma is regulated by mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB). Mice were subjected to trauma and splenic macrophages isolated 7 days later. Macrophages from traumatized mice showed increased cyclooxygenase-2 (COX-2) mRNA, protein expression, and PGE 2 production compared with controls. Increased phosphorylation of extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38 kinase was observed in macrophages from traumatized mice. Pharmacologic inhibition of MAPK blocked trauma-induced COX-2 expression, and PGE 2 production. Trauma macrophages showed increased IκBα phosphorylation and NF-κB binding to DNA. Inhibiting IκBα blocked trauma-induced NF-κB activity, COX-2 expression and PGE 2 production. This suggests that trauma-induced PGE 2 production is mediated through MAPK and NF-κB activation and offers potential for modifying the macrophages’ responses following injury.
ISSN:0008-8749
1090-2163
DOI:10.1016/j.cellimm.2005.03.001